Going for Leadership in Cellular Therapy

Going for Leadership in Cellular Therapy

June 26, 2014

NeoStem has positioned itself as a leader in the emerging cellular therapy industry, and opened the door toward launching a critical Phase 3 trial for melanoma, with the acquisition of biotech California Stem Cell (CSC), based in Irvine, California.

Click here to read the full article.